Zoledronic acid prevents disuse osteopenia and augments gene expression of osteoclastic differentiation markers in mice

OBJECTIVES: Disuse is characterized by a rapid and profound bone resorption. Zoledronic acid (Zol) inhibits osteoclastic bone resorption. The aim of the study was to prevent disuse osteopenia with Zol and investigate gene expression markers of osteoclastic differentiation. METHODS: Disuse osteopenia...

Full description

Saved in:
Bibliographic Details
Published in:J Musculoskelet Neuronal Interact
Main Authors: Vegger, Jens Bay, Brüel, Annemarie, Thomsen, Jesper Skovhus
Format: Artigo
Language:Inglês
Published: International Society of Musculoskeletal and Neuronal Interactions 2018
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6016491/
https://ncbi.nlm.nih.gov/pubmed/29855438
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items